Physician
Cipolla, Robert
Cipolla, Robert was paid $405K by Medicaid between Jan 2018 and Mar 2022, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 63% of everything it billed.
33Billing provider infoCIPOLLA, ROBERT
CLINTON, IL 61727
CLINTON, IL 61727
33aNPI1649370271assigned 09/24/2006
33bProvider typeFamily Medicine Physician
28Total paid$405K
24GClaims9,474
24DCodes billed12
24AFirst – last monthJan 2018 – Mar 2022
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#259 of 2,947
Median peer was paid$43K
This provider vs. median9.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,028 | $119K | |
| 2019 | 2,610 | $110K | |
| 2020 | 1,441 | $57K | |
| 2021 | 2,254 | $105K | |
| 2022 | 141 | $13K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 63% | 6,126 | 5,192 | $256K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 1,552 | 1,311 | $100K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 4.6% | 50 | 31 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.9% | 746 | 619 | $12K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.8% | 341 | 292 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 132 | 75 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 65 | 49 | $2K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 23 | 15 | $1K |
| 81002 | <1% | 356 | 311 | $915.43 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 44 | 41 | $431.64 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 24 | 19 | $283.08 |
| 81025 | <1% | 15 | 12 | $77.55 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.